Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Depression -
Lawmakers seek probe of disagreements at FDA Lawmakers seek probe of disagreements at FDA

Lawmakers seek probe of disagreements at FDA

DepressionJul 21, 2004

Two Republican lawmakers on Tuesday asked for an investigation into how health regulators handled internal disagreements such as the conflicting views over the risks of antidepressants.

Reps. Joe Barton and Jim Greenwood said their request was prompted by the Food and Drug Administration’s review of whether certain antidepressants might raise the risk of suicide in children and teenagers.

An FDA reviewer, Dr. Andrew Mosholder, concluded there was a link, but other agency officials disagreed. The FDA has not yet reached a determination.

Mosholder is a scientist in the FDA’s Office of Drug Safety. Staff from another division, the Center for Drug Evaluation and Research, decided Mosholder should not present his views at a February advisory committee meeting, according to a letter from the agency made public in April.

The lawmakers, in a letter, asked the Government Accountability Office (GAO) to explore past disagreements between the two divisions and whether “each of these cases resulted in appropriate regulatory action.”

Barton, from Texas, chairs the House Energy and Commerce Committee. Greenwood, from Pennsylvania, heads the panel’s investigations subcommittee.

In addition to the antidepressants review, the committee “has information raising questions about the handling of other disagreements” related to Roche acne drug Accutane, Aventis SA’s rheumatoid arthritis drug Arava, Johnson & Johnson’s withdrawn heartburn drug Propulsid and Pfizer’s withdrawn diabetes drug Rezulin.

An FDA spokeswoman did not immediately respond to a request for comment. Agency officials have defended their dealings with Mosholder, saying they acknowledged disagreement about the antidepressant data at the public advisory panel meeting. 

Provided by ArmMed Media
Revision date: June 18, 2011
Last revised: by Andrew G. Epstein, M.D.

Lawmakers seek probe of disagreements at FDA Bookmark this! Lawmakers seek probe of disagreements at FDA

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
What health info have you recently searched for online?
Disease or condition
Exercise or fitness
Diet, nutrition or vitamins
None of the above


Get free support - Headache Causes, Symptoms, Diagnosis, and Treatment on HeadacheCare.net


Health Centers







Diabetes

















Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback


Add to Yahoo RSS News Feed



Google Reader




Syndicate


This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:
Verify here.




Plan B prevent ovulation and pregnancy after unprotected sex

hit counter